Additionally, we also assayed the cytokine levels of TNF‐α and IFN‐γ within APCCs treated with anti‐PD1, anti‐PD1, and cabozantinib combination, as well as anti‐PD1 with CD15pos cells' removal in RCC patient‐derived APCCs. The gene discussed is IFNG; the disease is renal cell carcinoma.